Company news

TELA Bio, Inc. news in 2026

TELA Bio, Inc.'s news releases, calls and decks from 2026, newest first.

View company

TELA Bio to Announce Third Quarter 2026 Financial Results

October 27, 2026

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

October 5, 2026

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

August 31, 2026

TELA Bio Reports Second Quarter 2026 Financial Results

August 10, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)

August 6, 2026

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

August 4, 2026

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026

TELA Bio to Announce Second Quarter 2026 Financial Results

July 20, 2026

TELA Bio Reports First Quarter 2026 Financial Results

May 12, 2026

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

April 29, 2026

TELA Bio to Announce First Quarter 2026 Financial Results

April 21, 2026

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

March 23, 2026

TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results

March 9, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 23, 2026

Calls in 2026

Decks in 2026